{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:20:17Z","timestamp":1765891217143,"version":"3.48.0"},"reference-count":44,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Policy and Practice"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/20523211.2025.2523934","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T06:46:56Z","timestamp":1751957216000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Optimisation of lipid-lowering therapy post-Acute Coronary Syndromes: a multidisciplinary, cross-interface novel pharmacy care model within a local cardiac rehabilitation centre"],"prefix":"10.1080","volume":"18","author":[{"given":"Idil Z.","family":"Gul","sequence":"first","affiliation":[{"name":"University of Birmingham","place":["Birmingham, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Baig","sequence":"additional","affiliation":[{"name":"University of Birmingham","place":["Birmingham, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Glover","sequence":"additional","affiliation":[{"name":"Royal Wolverhampton NHS Trust","place":["Wolverhampton, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandeep","family":"Virdee","sequence":"additional","affiliation":[{"name":"Royal Wolverhampton NHS Trust","place":["Wolverhampton, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Osman","sequence":"additional","affiliation":[{"name":"University of Birmingham","place":["Birmingham, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Dudley Integrated Health and Care NHS Trust Health and Social Care Centre","place":["Brierley Hill, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-3379","authenticated-orcid":false,"given":"Zahraa","family":"Jalal","sequence":"additional","affiliation":[{"name":"University of Birmingham","place":["Birmingham, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-022-01517-1"},{"key":"e_1_3_3_3_1","unstructured":"BACPR. (2017). The BACPR standards and core components for cardiovascular disease prevention and rehabilitation 2017 (3rd Edition). https:\/\/www.bacpr.org\/__data\/assets\/pdf_file\/0026\/39437\/BACPR_Standards_and_Core_Components_2017.pdf."},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.09l00940yel"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105499"},{"key":"e_1_3_3_6_1","unstructured":"British Heart Foundation. (2023). Cardiac rehabilitation. Bhf.org.uk; British Heart Foundation. https:\/\/www.bhf.org.uk\/informationsupport\/support\/practical-support\/cardiac-rehabilitation."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/1474515117693891"},{"key":"e_1_3_3_8_1","unstructured":"Burns C. (2022). Independent prescribing pharmacist numbers total 15 000 increasing by two-thirds in two years. The Pharmaceutical Journal. https:\/\/pharmaceutical-journal.com\/article\/news\/independent-prescribing-pharmacist-numbers-total-15000-increasing-by-two-thirds-in-two-years."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/life13040950"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13210"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23988"},{"key":"e_1_3_3_12_1","volume-title":"Lipid lowering drug therapy","author":"Chhetry M.","year":"2021","unstructured":"Chhetry, M., & Jialal, I. (2021). Lipid lowering drug therapy. StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK541128\/."},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23773"},{"key":"e_1_3_3_14_1","unstructured":"Connelly D. Cohen D. & McCartney M. (2023). Fewer than 5 000 people prescribed anticholesterol drug inclisiran in primary care as of July 2023. The Pharmaceutical Journal. https:\/\/pharmaceutical-journal.com\/article\/news\/fewer-than-5000-people-prescribed-anticholesterol-drug-inclisiran-in-primary-care-as-of-july-2023."},{"key":"e_1_3_3_15_1","unstructured":"Connolly D. L. Zaman A. Capps N. C. Bain S. C. & Fernando K. (2023). Assessing opinion on lower LDL-cholesterol lowering and the role of newer lipid-reducing treatment options. The British Journal of Cardiology 30(69). https:\/\/bjcardio.co.uk\/2023\/05\/assessing-opinion-on-lower-ldl-cholesterol-lowering-and-the-role-of-newer-lipid-reducing-treatment-options\/."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23935"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2018-136171"},{"key":"e_1_3_3_18_1","unstructured":"European Society of Cardiology. (2022). Statin intolerance is \u201cover-estimated and over-diagnosed.\u201d https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/Statin-intolerance-is-over-estimated-and-over-diagnosed#:~:text=Now%2C%20a%20new%20study%20of."},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.0083"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.649181"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12027"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.5837\/bjc.2022.034"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35463"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.5837\/bjc.2022.035"},{"key":"e_1_3_3_25_1","unstructured":"Khatib R. & Neely D. (2022). Statin intolerance pathway. NHS England. https:\/\/www.england.nhs.uk\/aac\/wp-content\/uploads\/sites\/50\/2020\/04\/statin-intolerance-pathway-v2.pdf."},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0013"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02257-6"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-6-s43"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0613-0"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.123.030414"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-023-01562-4"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-020-01326-w"},{"key":"e_1_3_3_33_1","unstructured":"National Health Service Education England. (2018). Integrated care. Health Education England. https:\/\/www.hee.nhs.uk\/our-work\/integrated-care#:~:text=It%20is%20care%20that%20is."},{"key":"e_1_3_3_34_1","unstructured":"NHS. (2022). Cholesterol Levels \u2013 High Cholesterol. https:\/\/www.nhs.uk\/conditions\/high-cholesterol\/cholesterol-levels\/."},{"key":"e_1_3_3_35_1","unstructured":"NHS. (n.d.). Accelerated Access Collaborative Lipid Management \u2013 Rapid Uptake Product. https:\/\/www.england.nhs.uk\/aac\/what-we-do\/innovation-for-healthcare-inequalities-programme\/rapid-uptake-products\/lipid-management\/."},{"key":"e_1_3_3_36_1","unstructured":"NICE. (2021). Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia. NICE. https:\/\/www.nice.org.uk\/guidance\/ta733\/chapter\/1-Recommendations."},{"key":"e_1_3_3_37_1","unstructured":"NICE. (2022). CVD escalation of therapy for secondary prevention scope stakeholder subgroup discussions. NICE. https:\/\/www.nice.org.uk\/guidance\/ng238\/documents\/workshop-notes-2."},{"key":"e_1_3_3_38_1","unstructured":"NICE. (2023a). CKS is only available in the UK. NICE. https:\/\/cks.nice.org.uk\/topics\/lipid-modification-cvd-prevention\/management\/lipid-therapy-secondary-prevention-of-cvd\/."},{"key":"e_1_3_3_39_1","unstructured":"NICE. (2023b). Cardiovascular disease: risk assessment and reduction including lipid modification NICE. https:\/\/www.nice.org.uk\/guidance\/ng238\/chapter\/Recommendations."},{"issue":"3","key":"e_1_3_3_40_1","first-page":"113","article-title":"Pharmacist\u2019s role in an interdisciplinary cardiac rehabilitation team","volume":"41","author":"Packard K.","year":"2012","unstructured":"Packard, K., Herink, M., & Kuhlman, P. (2012). Pharmacist\u2019s role in an interdisciplinary cardiac rehabilitation team. Journal of Allied Health, 41(3), 113\u2013117. 117a, 117b. https:\/\/pubmed.ncbi.nlm.nih.gov\/22968772\/.","journal-title":"Journal of Allied Health"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1177\/2047487320905719"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062161"},{"key":"e_1_3_3_43_1","volume-title":"Acute coronary syndrome","author":"Singh A.","year":"2021","unstructured":"Singh, A., Museedi, A. S., & Grossman, S. A. (2021). Acute coronary syndrome. PubMed; StatPearls Publishing. https:\/\/pubmed.ncbi.nlm.nih.gov\/29083796\/."},{"key":"e_1_3_3_44_1","unstructured":"Terry M. & Mills J. (2017). The post-ACS patient: Shared care to improve outcomes. The British Journal of Cardiology. https:\/\/bjcardio.co.uk\/2017\/09\/the-post-acs-patient-shared-care-to-improve-outcomes\/."},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/ehjqcco\/qcz052"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2025.2523934","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:16:41Z","timestamp":1765891001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20523211.2025.2523934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/20523211.2025.2523934"],"URL":"https:\/\/doi.org\/10.1080\/20523211.2025.2523934","relation":{},"ISSN":["2052-3211"],"issn-type":[{"value":"2052-3211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2523934"}}